The DOI matches its Crossref record; 260 of the 260 references it cites were found in a registry or an index.
YAP/TAZ: Drivers of Tumor Growth, Metastasis, and Resistance to Therapy
Open accessAbstract
The transcriptional co‐activators YAP (or YAP1) and TAZ (or WWTR1) are frequently activated during the growth and progression of many solid tumors, including lung, colorectal, breast, pancreatic, and liver carcinomas as well as melanoma and glioma. YAP/TAZ bind to TEAD‐family co‐activators to drive cancer cell survival, proliferation, invasive migration, and metastasis. YAP/TAZ activation may also confer resistance to chemotherapy, radiotherapy, or immunotherapy. YAP‐TEAD cooperates with the RAS‐induced AP‐1 (FOS/JUN) transcription factor to drive tumor growth and cooperates with MRTF‐SRF to promote activation of cancer‐associated fibroblasts, matrix stiffening, and metastasis. The key upstream repressor of YAP/TAZ activation is the Hippo (MST1/2‐LATS1/2) pathway and the key upstream activators are mechanically induced Integrin‐SRC and E‐cadherin‐AJUBA/TRIP6/LIMD1, growth factor induced PI3K‐AKT, and inflammation‐induced G‐protein coupled receptor (GPCR) signals, all of which antagonize the Hippo pathway. In this review, strategies to target YAP/TAZ activity in cancer are discussed along with the prospects for synergy with established pillars of cancer therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Items 201–260 of 260
García‐Escudero, R., Segrelles, C., Dueñas, M., Pombo, M. T., Ballestín, C., Alonso, M., Nenclares, P., Álvarez‐Rodríguez, R., Aniceto, G. S., Ruiz-Alonso, A., et al. (2018) · Oral Oncology · doi:10.1016/j.oraloncology.2018.02.014 · Cited by 79
Jiang, N., Hjorth-Jensen, K., Hekmat, O., Iglesias‐Gato, D., Kruse, T., Wang, C., Wei, W., Ke, B., Yan, B., Niu, Y., et al. (2014) · Oncogene · doi:10.1038/onc.2014.206 · Cited by 78
Yuan, W., Stawiski, E. W., Janakiraman, V., Chan, E., Durinck, S., Edgar, K. A., Kljavin, N. M., Rivers, C. S., Gnad, F., Roose‐Girma, M., et al. (2012) · Oncogene · doi:10.1038/onc.2012.53 · Cited by 78
TAZ and YAP are frequently activated oncoproteins in sarcomas
Fullenkamp, C. A., Hall, S. L., Jaber, O. I., Pakalniskis, B. L., Savage, E. C., Savage, J. M., Ofori-Amanfo, G. K., Lambertz, A. M., Ivins, S. D., Stipp, C. S., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8979 · Cited by 78
He, C., Lv, X., Huang, C., Angeletti, P. C., Hua, G., Dong, J., Zhou, J. R., Wang, Z., Ma, B., Chen, X., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.02.004 · Cited by 77
Regulation of SRF Activity by Rho Family GTPasesPreprint
Treisman, R., Alberts, A. S., & Sahai, E. A. (1998) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.1998.63.643 · Cited by 73
YAP-associated chromosomal instability and cholangiocarcinoma in mice
Rizvi, S. H., Fischbach, S. R., Bronk, S. F., Hirsova, P., Krishnan, A., Dhanasekaran, R., Smadbeck, J. B., Smoot, R. L., Vasmatzis, G., & Gores, G. J. (2017) · Oncotarget · doi:10.18632/oncotarget.23638 · Cited by 73
Upstairs, downstairs: spatial regulation of Hippo signalling
Fulford, A. D., Tapon, N., & Ribeiro, P. S. (2017) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2017.10.006 · Cited by 72
PI3K Positively Regulates YAP and TAZ in Mammary Tumorigenesis Through Multiple Signaling Pathways
Zhao, Y., Montminy, T., Azad, T., Lightbody, E. D., Hao, Y., Sengupta, S., Asselin, É., Nicol, C. J. B., & Yang, X. (2018) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-17-0593 · Cited by 72
Smoot, R. L., Werneburg, N. W., Sugihara, T., Hernandez, M. C., Yang, L., Mehner, C., Graham, R. P., Bronk, S. F., Truty, M. J., & Gores, G. J. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26246 · Cited by 71
TRIP6 inhibits Hippo signaling in response to tension at adherens junctions
Dutta, S., Mana‐Capelli, S., Paramasivam, M., Dasgupta, I., Cirka, H. A., Billiar, K., & McCollum, D. (2017) · EMBO Reports · doi:10.15252/embr.201744777 · Cited by 71
Jiang, Z., Zhou, C., Cheng, L., Yan, B., Chen, K., Chen, X., Zong, L., Lei, J., Duan, W., Xu, Q., et al. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0740-4 · Cited by 71
Oroxylin A prevents angiogenesis of LSECs in liver fibrosis via inhibition of YAP/HIF‐1α signaling
Zhang, C., Bian, M., Chen, X., Jin, H., Zhao, S., Xiang, Y., Shao, J., Chen, A., Guo, Q., Zhang, F., et al. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26388 · Cited by 70
CAO, J.-J., Zhao, X., Wang, D., Chen, K.-H., SHENG, X., Li, W., Li, M., Liu, W., & HE, J. (2014) · Oncology Reports · doi:10.3892/or.2014.3349 · Cited by 68
Insulin Receptor and GPCR Crosstalk Stimulates YAP via PI3K and PKD in Pancreatic Cancer Cells
Fang, H., Xu, Q., Zhao, Y., Stevens, J. V., Young, S. H., Sinnett‐Smith, J. W., & Rozengurt, E. (2017) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-17-0023 · Cited by 68
Kostic, M., Paridaen, J. T. M. L., Long, K. R., Kalebic, N., Langen, B., Grübling, N., Wimberger, P., Kawasaki, H., Namba, T., & Huttner, W. Β. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.03.091 · Cited by 68
Li, X., Tao, J., Cigliano, A., Sini, M., Caldéraro, J., Azoulay, D., Wang, C., Liu, Y., Jiang, L., Evert, K., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3546 · Cited by 65
Ma, X., Zhang, H., Xue, X., & Shah, Y. M. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.805655 · Cited by 64
Guo, P.-D., Lu, X.-X., Gan, W.-J., Li, X., He, X., Zhang, S., Ji, Q., Zhou, F., Cao, Y. Z., Wang, J., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-2882 · Cited by 63
Targeting YAP in malignant pleural mesothelioma
Zhang, W., Dai, Y., Hsu, P., Wang, H., Cheng, L., Yang, Y., Wang, Y., Xu, Z., Liu, S., Chan, G., et al. (2017) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13182 · Cited by 63
An, Y., Adams, J. R., Hollern, D. P., Zhao, A., Chang, S. G., Gams, M. S., Chung, P. E. D., He, X., Jangra, R., Shah, J. S., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.09.056 · Cited by 63
Yu, O. M., Benitez, J. A., Plouffe, S. W., Ryback, D., Klein, A., Smith, J., Greenbaum, J., Delatte, B., Rao, A., Guan, K.-L., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0301-5 · Cited by 62
Xie, D., Cui, J., Xia, T., Jia, Z., Wang, L., Wei, W.-F., Zhu, A., Gao, Y., Xie, K., & Quan, M. (2015) · Oncotarget · doi:10.18632/oncotarget.5772 · Cited by 60
YAP and TAZ are dispensable for physiological and malignant haematopoiesis
Donato, E., Biagioni, F., Bisso, A., Cagánová, M., Amati, B. B., & Campaner, S. (2018) · Leukemia · doi:10.1038/s41375-018-0111-3 · Cited by 60
GPCRs Signaling Directly Through Src-Family Kinases
McGarrigle, D. K., & Huang, X. (2007) · Science s STKE · doi:10.1126/stke.3922007pe35 · Cited by 58
Pierpont, T. M., Lyndaker, A. M., Anderson, C. M., Jin, Q., Moore, E. S., Roden, J., Braxton, A. M., Bagepalli, L., Kataria, N., Hu, H. Z., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.10.078 · Cited by 56
The Role and Clinical Significance of Yes-Associated Protein 1 in Human Osteosarcoma
Zhang, Y.-H., Li, B., Shen, L., Shen, Y., & Chen, X. (2013) · International Journal of Immunopathology and Pharmacology · doi:10.1177/039463201302600115 · Cited by 54
Rybarczyk, A., Kłącz, J., Wrońska, A., Matuszewski, M., Kmieć, Z., & Wierzbicki, P. M. (2017) · Oncology Reports · doi:10.3892/or.2017.5642 · Cited by 54
Sun, J., Wang, X., Tang, B., Liu, H., Zhang, M., Wang, Y., Ping, F., Ding, J., Shen, A., & Geng, M. (2018) · Theranostics · doi:10.7150/thno.23964 · Cited by 54
Wang, J., Su, M., Fan, J., Seth, A. K., & McCulloch, C. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203130200 · Cited by 50
Structural and ligand-binding analysis of the YAP-binding domain of transcription factor TEAD4
Li, Y., Liu, S., Ng, E. Y., Li, R., Poulsen, A., Hill, J., Pobbati, A. V., Hung, A. W., Hong, W., Keller, T. H., et al. (2018) · Biochemical Journal · doi:10.1042/bcj20180225 · Cited by 46
Somatic Hypermutation of the YAP Oncogene in a Human Cutaneous Melanoma
Zhang, X., Tang, J., Vergara, I. A., Zhang, Y., Szeto, P., Yang, L., Mintoff, C., Colebatch, A. J., McIntosh, L., Mitchell, K. A., et al. (2019) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-18-0407 · Cited by 45
Hippo Reprograms the Transcriptional Response to Ras Signaling
Pascual, J., Jacobs, J., Sansores-García, L., Natarajan, M., Zeitlinger, J., Aerts, S., Halder, G. A., & Hamaratoǧlu, F. (2017) · Developmental Cell · doi:10.1016/j.devcel.2017.08.013 · Cited by 44
Lin, S., Lee, H.-C., Hou, P., Fu, J.-L., Wu, M., & Tsai, S. (2017) · The Journal of Pathology · doi:10.1002/path.4922 · Cited by 43
Feng, Y., Yang, S., Zhang, B., & Wei, B. (2016) · OncoTargets and Therapy · doi:10.2147/ott.s102733 · Cited by 42
Chen, G., Xie, J., Huang, P. C., & Yang, Z. (2016) · Oncology Letters · doi:10.3892/ol.2016.4829 · Cited by 41
Knockdown of YAP1 inhibits the proliferation of osteosarcoma cells in vitro and in vivo
Yang, Z., ZHANG, M., Xu, K., Liu, L., Hou, W., Cai, Y., Xu, P., & Yao, J. (2014) · Oncology Reports · doi:10.3892/or.2014.3305 · Cited by 40
The core and conserved role of MAL is homeostatic regulation of actin levelsPreprint
Salvany, L., Müller, J., Guccione, E., & Rørth, P. (2014) · Genes & Development · doi:10.1101/gad.237743.114 · Cited by 39
Role of YAP in lung cancer resistance to cisplatin
Song, J., Xie, L., Zhang, X., Hu, P., Long, M., Xiong, F., Huang, J., & Ye, X. (2018) · Oncology Letters · doi:10.3892/ol.2018.9141 · Cited by 39
McMichael, B. K., Meyer, S. M., & Lee, B. S. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.119909 · Cited by 38
Mendoza‐Reinoso, V., & Beverdam, A. (2018) · Stem Cell Research · doi:10.1016/j.scr.2018.03.005 · Cited by 38
Hippo Cascade Controls Lineage Commitment of Liver Tumors in Mice and Humans
Zhang, S., Wang, J., Wang, H., Fan, L., Fan, B., Zeng, B., Tao, J., Li, X., Che, L., Cigliano, A., et al. (2018) · American Journal Of Pathology · doi:10.1016/j.ajpath.2017.12.017 · Cited by 37
A novel Src kinase inhibitor reduces tumour formation in a skin carcinogenesis model
Serrels, B., Serrels, A., Mason, S. M., Baldeschi, C., Ashton, G. H. S., Canel, M., Mackintosh, L. J., Doyle, B. J., Green, T. P., Frame, M. C., et al. (2008) · Carcinogenesis · doi:10.1093/carcin/bgn278 · Cited by 36
Src and STAT3 inhibitors synergize to promote tumor inhibition in renal cell carcinoma
Lue, H.-W., Cole, B. C., Rao, S. A. M., Podolak, J., Gaest, A. V., King, C. J., Eide, C. A., Wilmot, B., Xue, C., Spellman, P. T., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5971 · Cited by 36
Rao, G., Kim, I.-K., Conforti, F., Liu, J., Zhang, Y.-W., & Giaccone, G. (2018) · European Journal of Cancer · doi:10.1016/j.ejca.2018.05.013 · Cited by 34
Role of Src Family Kinases in Regulation of Intestinal Epithelial Homeostasis
Imada, S., Murata, Y., Kotani, T., Hatano, M., Sun, C., Konno, T., Park, J., Kitamura, Y., Saito, Y., Ohdan, H., et al. (2016) · Molecular and Cellular Biology · doi:10.1128/mcb.00311-16 · Cited by 33
Dong, L., Lin, F., Wu, W., Huang, W., & Cai, Z. (2016) · Journal of Cancer · doi:10.7150/jca.16438 · Cited by 32
Shanzer, M., Adler, J., Ricardo-Lax, I., Reuven, N. B., & Shaul, Y. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1610223114 · Cited by 32
Lee, S. E., Lee, J. U., Lee, M. H., Ryu, M. J., Kim, S. J., Kim, Y. K., Choi, M. J., Kim, K. S., Kim, J., Kim, J. W., et al. (2013) · Oncogenesis · doi:10.1038/oncsis.2013.12 · Cited by 29
Sphingosine-1-phosphate promotes ovarian cancer cell proliferation by disrupting Hippo signaling
Fan, Q., Cheng, Y., Chang, H., Deguchi, M., Hsueh, A. J. W., & Leung, P. C. K. (2017) · Oncotarget · doi:10.18632/oncotarget.15677 · Cited by 27
Abduch, R. H., Bueno, A. C., Leal, L. F., Cavalcanti, M. M., Gomes, D. C., Brandalise, S. R., Masterallo, M. J., Yunes, J. A., Martinelli, C. E., Tone, L. G., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.12382 · Cited by 26
Inhibition of Translesion DNA Synthesis as a Novel Therapeutic Strategy to Treat Brain Cancer
Choi, J.-S., Kim, C. S., & Berdis, A. J. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-2464 · Cited by 26
The MRTF-A/B function as oncogenes in pancreatic cancer
Zhao, S., Liu, Z., Sun, J., Sun, F., LI, C.-Z., Sun, J., & Xu, L. (2015) · Oncology Reports · doi:10.3892/or.2015.4329 · Cited by 25
Akladios, B., Mendoza‐Reinoso, V., Samuel, M. S., Hardeman, E. C., Khosrotehrani, K., Key, B., & Beverdam, A. (2016) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2016.10.029 · Cited by 24
YAP knockdown inhibits proliferation and induces apoptosis of human prostate cancer DU145 cells
Jin, X., Zhao, W., Zhou, P., & Niu, T. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.8352 · Cited by 20
SRF is essential for mesodermal cell migration during elongation of the embryonic body axis
Schwartz, B., Marks, M., Wittler, L., Werber, M., Währisch, S., Nordheim, A., Herrmann, B. G., & Grote, P. (2014) · Mechanisms of Development · doi:10.1016/j.mod.2014.07.001 · Cited by 19
Role and regulation of Yap in KrasG12D-induced lung cancer
Mao, Y., Sun, S., & Irvine, K. D. (2017) · Oncotarget · doi:10.18632/oncotarget.22865 · Cited by 17
Small-sized colorectal cancer cells harbor metastatic tumor-initiating cells
Mu, L., Huang, K., Hu, Y., Chang, Y., Li, X., Tao, D., Gong, J., & Qin, J. (2017) · Oncotarget · doi:10.18632/oncotarget.22392 · Cited by 16
Yan, B., Li, T., Shen, L., Zhou, Z., Liu, X., Wang, X., & Sun, X. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.05.143 · Cited by 13
Role of YAP-1 in Thyroid Tumor Progression and Outcome
Ugolini, C., Borrelli, N., Niccoli, C., Elisei, R., Viola, D., Vitti, P., Miccoli, P., & Basolo, F. (2016) · Applied immunohistochemistry & molecular morphology · doi:10.1097/pai.0000000000000344 · Cited by 10
Cited by
Insights into recent findings and clinical application of YAP and TAZ in cancer
Franklin, J. M., Wu, Z., & Guan, K.-L. (2023) · Nature Reviews Cancer · doi:10.1038/s41568-023-00579-1 · Cited by 213
Therapeutic targeting of TEAD transcription factors in cancer
Pobbati, A. V., Kumar, R., Rubin, B. P., & Hong, W. (2023) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2022.12.005 · Cited by 147
Drugs Targeting p53 Mutations with FDA Approval and in Clinical Trials
Nishikawa, S., & Iwakuma, T. (2023) · Cancers · doi:10.3390/cancers15020429 · Cited by 115
Endothelial YAP/TAZ Signaling in Angiogenesis and Tumor Vasculature
Hooglugt, A., van der Stoel, M. M., Boon, R. A., & Huveneers, S. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2020.612802 · Cited by 82
Zhao, W., Yuan, W., Dong, T., Qi, W., Feng, Z., Li, C., & Sun, Y. (2025) · Communications Biology · doi:10.1038/s42003-025-08160-2 · Cited by 16
Metadata
- Authors
- Thompson, B. J.
- Venue
- BioEssays
- Publisher
- Wiley
- Published
- 2020-03-04
- Volume
- 42
- Issue
- 5
- Pages
- e1900162-e1900162
- ISSN
- 0265-9247 (ISSN-L)
- 1521-1878
- OpenAlex
- W3009146905
- Cited by
- 259
- References
- 260
- FWCI
- 4.09
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.